Xavier Majó
Biographic Data
| ID | 6807153 |
|---|---|
| NAME | Xavier Majó |
| GIVEN NAMES | Xavier |
| FAMILY NAME | Majó |
| SIGNATURE | MAJÓ X |
| AFFILIATIONS | Agència de Salut Pública de Catalunya |
| VERIFIED | No |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Design and results of a pilot community screening strategy for hepatitis B and hepatitis C to promote early access to treatment among migrant populations from high-prevalence countries residing in Cat…
Introduction : The elimination of hepatitis C virus (HCV) and hepatitis B virus (HBV) requires strategies to overcome barriers associated with access to healthcare among migrants. The objective was to design and implement a community-screening-strategy (MiCat) for HBV and HCV among migrant populations from high-prevalence countries residing in Catalonia. Methodology : A pilot community-screening was conducted in religious sites, associations or c…
Trends in the prevalence of HIV, HCV, and co-infection and associated factors among young people who inject drugs (PWID) in Catalonia (2008–2019)
People who inject drugs (PWID) face a significantly increased risk of blood-borne virus (BBV) infections, including HIV and hepatitis C virus (HCV), as well as co-infections. To better understand this issue, bio-behavioral surveillance studies were conducted among PWID attending harm reduction facilities in Catalonia, forming part of the comprehensive Integrated HIV/STI Surveillance System since 2008. The goal of this study was to describe the pr…
The hepatitis C care cascade among people who inject drugs accessing harm reduction services in Catalonia: Major gaps for migrants
Integration of harm reduction and treatment into care centres for substance use: The Barcelona model
Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia
Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits
Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: A pilot study
UNLABELLED: Including HCV and HIV rapid tests in harm reduction programmes (HRP) for people who inject drugs (PWID) can increase detection of these infections in high-risk populations who do not seek conventional health care. AIMS: To assess acceptability and feasibility of rapid HIV and HCV tests in HRP; to identify HIV and HCV prevalence rates in HRP; to identify the percentage of PWID with a reactive test that attend hospital for confirmation …
Cross sectional study of factors associated to self-reported blood-borne infections among drug users
Among drug users in Catalonia, HIV, HCV and co-infection prevalence are still a big issue especially among IDUs. Women and drug users who have never injected drugs are groups with a significant risk of infection; this might be related to their high-risk behaviours and to being unaware of their serological status
No prominent works on this page.
Cross sectional study of factors associated to self-reported blood-borne infections among drug users
Among drug users in Catalonia, HIV, HCV and co-infection prevalence are still a big issue especially among IDUs. Women and drug users who have never injected drugs are groups with a significant risk of infection; this might be related to their high-risk behaviours and to being unaware of their serological status
Implementation of rapid HIV and HCV testing within harm reduction programmes for people who inject drugs: A pilot study
UNLABELLED: Including HCV and HIV rapid tests in harm reduction programmes (HRP) for people who inject drugs (PWID) can increase detection of these infections in high-risk populations who do not seek conventional health care. AIMS: To assess acceptability and feasibility of rapid HIV and HCV tests in HRP; to identify HIV and HCV prevalence rates in HRP; to identify the percentage of PWID with a reactive test that attend hospital for confirmation …
Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits
Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia
Integration of harm reduction and treatment into care centres for substance use: The Barcelona model
The hepatitis C care cascade among people who inject drugs accessing harm reduction services in Catalonia: Major gaps for migrants
Trends in the prevalence of HIV, HCV, and co-infection and associated factors among young people who inject drugs (PWID) in Catalonia (2008–2019)
People who inject drugs (PWID) face a significantly increased risk of blood-borne virus (BBV) infections, including HIV and hepatitis C virus (HCV), as well as co-infections. To better understand this issue, bio-behavioral surveillance studies were conducted among PWID attending harm reduction facilities in Catalonia, forming part of the comprehensive Integrated HIV/STI Surveillance System since 2008. The goal of this study was to describe the pr…
Design and results of a pilot community screening strategy for hepatitis B and hepatitis C to promote early access to treatment among migrant populations from high-prevalence countries residing in Cat…
Introduction : The elimination of hepatitis C virus (HCV) and hepatitis B virus (HBV) requires strategies to overcome barriers associated with access to healthcare among migrants. The objective was to design and implement a community-screening-strategy (MiCat) for HBV and HCV among migrant populations from high-prevalence countries residing in Catalonia. Methodology : A pilot community-screening was conducted in religious sites, associations or c…
HIV, Drug Use, Sexual Risk (7 works) · Medicine (7 works) · Harm reduction (6 works) · Hepatitis C (5 works) · Hepatitis C virus research (5 works) · Hepatitis B Virus Studies (4 works) · Human immunodeficiency virus (HIV (4 works) · Internal Medicine (4 works) · Public health (4 works) · Environmental health (3 works)